Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 3598 | 270 | 0.1685 | 0.1621 | 0.0750 | 0.0672 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 1025 | 184 | 0.0426 | 0.0433 | 0.1795 | 0.1874 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 1189 | 229 | 0.0486 | 0.0433 | 0.1926 | 0.1874 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 947 | 180 | 0.0388 | 0.0433 | 0.1901 | 0.1874 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 1265 | 271 | 0.0503 | 0.0434 | 0.2142 | 0.1958 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 2 | 1025 | 203 | 0.0416 | 0.0434 | 0.1980 | 0.1958 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 914 | 160 | 0.0382 | 0.0434 | 0.1751 | 0.1958 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 1196 | 197 | 0.0506 | 0.0492 | 0.1647 | 0.1635 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 1138 | 197 | 0.0477 | 0.0492 | 0.1731 | 0.1635 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 1153 | 176 | 0.0495 | 0.0492 | 0.1526 | 0.1635 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 22233 | 990 | 1.0180 | 1.0000 | 0.0445 | 0.0468 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 21096 | 999 | 0.9631 | 1.0000 | 0.0474 | 0.0468 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 22342 | 1082 | 1.0188 | 1.0000 | 0.0484 | 0.0468 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 16963 | 834 | 0.7730 | 0.8197 | 0.0492 | 0.0506 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 18341 | 936 | 0.8341 | 0.8197 | 0.0510 | 0.0506 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 18747 | 969 | 0.8520 | 0.8197 | 0.0517 | 0.0506 |
A-375 | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 9567 | 390 | 0.4398 | 0.4342 | 0.0408 | 0.0408 |
A-375 | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 10229 | 430 | 0.4696 | 0.4342 | 0.0420 | 0.0408 |
A-375 | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 8546 | 338 | 0.3934 | 0.4342 | 0.0396 | 0.0408 |
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 2168 | 298 | 0.0896 | 0.0889 | 0.1375 | 0.1262 |
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 2198 | 268 | 0.0925 | 0.0889 | 0.1219 | 0.1262 |
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 2006 | 239 | 0.0847 | 0.0889 | 0.1191 | 0.1262 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 13441 | 248 | 0.6323 | 0.4565 | 0.0185 | 0.0200 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 8056 | 164 | 0.3782 | 0.4565 | 0.0204 | 0.0200 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 7654 | 162 | 0.3590 | 0.4565 | 0.0212 | 0.0200 |